Antibodies Mark Strong Immune Response in Older Persons After COVID-19
Investigators conducted a large longitudinal study to assess antibody avidity observed after SARS-CoV-2 infection across adult age groups.
General Rheumatology
Delta Variant Now Causing More Than 50% of US COVID-19 Cases
The highly contagious Delta variant now accounts for more than half of all new coronavirus infections in the United States, new government data show.
ACP Releases Practice Advice for Short-Course Antibiotics in Common Infections
The American College of Physicians convened a panel to identify best practices for the use of short-course antibiotics in the management of common infections.
Tool Estimates Mortality Risk for Older Adults Using Home Care
A new mortality risk prediction tool can help predict death and need for end-of-life care for frail older adults.
Two-Dose Novavax Vaccine Protects Against SARS-CoV-2 Infection
A two-dose regimen of the NVX-CoV2373 (Novavax) recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has efficacy of 89.7% in adults.
Britain to Fully Reopen Soon, Despite Rising COVID-19 Cases
Face mask and social-distancing laws will be lifted in Britain later this month and British citizens will have to “learn to live with the virus,” Prime Minister Boris Johnson said Monday.
COVID-19 Outcomes Assessed Among Patients With Autoimmune Inflammatory Rheumatic Diseases in South Korea
Researchers conducted a nationwide cohort study to determine the association between autoimmune inflammatory rheumatic diseases and COVID-19 in South Korea, early in the pandemic.
Early Risers Have Lower Risk for Depression
The researchers examined this question: Does a tendency toward sleeping and waking earlier have a potential causal role in reducing the risk of major depressive disorder?
Exercising With a Mask Safe, Does Not Impact Exercise Capacity
Exercising with a mask does not seem to limit actual exercise capacity.
Janssen Vaccine Protects Against Delta Variant, Company Says
Johnson & Johnson announced Thursday that its COVID-19 vaccine is effective against the highly contagious Delta variant that brought India to its knees this past spring.
- Loading...
Loading...
Next post in General Rheumatology
Loading... 
Loading...